Search results

This book is one of four volumes on a major empirical migration study by leading Thai migration specialists from Chulalongkorn University (Bangkok) for the United Nations Development Programme (UNDP). This volume examines the protracted refugee situation at the Thai-Myanmar border. Displaced persons are kept in closed settlements, and this has limited their self-reliance. A resettlement program has been implemented and many refugees have been accepted in resettlement countries. Repatriation is not recommended as a durable solution unless Myanmar becomes a safe place for return. Funding and intervention policies of international organizations and NGOs vary. Donors prefer to switch humanitarian assistance to development aid. The book provides realistic policy recommendations for a durable solution for refugees at the borders. Practitioners and policymakers from governments, international organizations and NGOs will benefit from its findings. The volume is also helpful for anyone studying forced migration and its denouement in the globalized age

This article revisits the conceptualisation of pharmaceutical regulation. While States and multilateral organisations play a central part in devising rules, regulation as a social practice extends beyond their role. Domestic and international interests, geopolitics and spatial configurations, commercial and health considerations, governmental policies and individual behaviours and legal and illegal transactions all contribute to regulating the pharmaceutical milieu. This consideration expands the epistemological range of pharmaceutical regulation, which then appears as the assemblage of heterogeneous laws, rules and codes of conducts. The way in which these layers are connected forms what regulation actually is in practice. Regulation multiple thus appears as the product of tensions between harmonisation efforts and persistent diversity, as well as the result of interactions and overlaps between official regulation and unofficial regulatory practices. This article explores these tensions in the Southeast Asian pharmaceutical market along three themes: circuits and logistic regimes; control and attention to quality; bridges and harmonisations.